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PAcute Coronary Syndrome
he Influence of Race on Health Status
utcomes One Year After an Acute Coronary Syndrome
ohn Spertus, MD, MPH,*†‡ David Safley, MD,*†‡ Mukesh Garg, MD,†‡ Philip Jones, MS,*
ric D. Peterson, MD, MPH§
ansas City, Missouri; and Durham, North Carolina
OBJECTIVES The goal of this study was to compare health status (symptoms, function, and quality of life)
outcomes of whites and blacks one year after an acute coronary syndrome (ACS).
BACKGROUND Although racial differences in the use of angiography and revascularization after ACS are
known to exist, differences in health status outcomes have not been described.
METHODS We conducted a prospective registry of 1,159 consecutive ACS patients treated between
February 1, 2000 and October 31, 2001. One-year health status was quantified with the
Seattle Angina Questionnaire (SAQ) and Short Form-12 Physical Component Score (SF-12
PCS). Multivariable models were used to adjust for racial differences in sociodemographic,
clinical, and treatment characteristics.
RESULTS Mortality rates were similar among the 196 black and 963 white patients (7.1% vs. 7.0%,
p  0.93); 81 died during follow-up, and 199 (17%) could not be interviewed. At one
year, blacks had a higher prevalence of angina (43.4% vs. 27.1%), worse quality of life (SAQ
score  70.6  28.3 vs. 83.9  20.8), and poorer physical function (SF-12 PCS  36.8 
12.3 vs. 43.2 11.4; p 0.0001 for all). Multivariable models, including hospital treatments,
revealed a trend for more angina (odds ratio 1.46 [95% confidence interval 0.91 to 2.34]) and
significantly worse quality of life (mean difference  7.7  2.4, p  0.002) and physical
function (3.6  1.3, p  0.005).
CONCLUSIONS Blacks have more angina, worse quality of life, and worse physical function one year after an
ACS than do whites. Closer surveillance of black ACS patients is needed to determine
whether additional treatment can improve their outcomes. (J Am Coll Cardiol 2005;46:
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.05.0921838–44) © 2005 by the American College of Cardiology Foundation
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enderstanding and rectifying racial disparities in healthcare
s a national priority (1) and a primary goal of the Depart-
ent of Health and Human Services’ Healthy People 2010
genda (2). Much of the impetus for addressing racial
isparities has arisen from studies documenting that black
nd white patients with coronary artery disease are treated
See page 1852
ifferently. For example, numerous investigations have
emonstrated that blacks have lower rates of angiography
nd revascularization (3–5). Yet, understanding whether
hese differences in care result in racial disparities requires
emonstrating that adverse consequences (i.e., worse
linical outcomes) result from these different treatment
atterns.
When previous investigators have examined outcomes
ssociated with differences in care, they have focused upon
ortality and have demonstrated few significant differences
n the survival of black and white patients (6,7). While a
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issouri; †University of Missouri-Kansas City, Kansas City, Missouri; ‡Truman
edical Center, Kansas City, Missouri; and §Duke University Medical Center,
urham, North Carolina. This project was supported by R-01 HS11282-01 from the
gency for Healthcare Research and Quality.p
Manuscript received January 22, 2005; revised manuscript received April 25, 2005,
ccepted May 2, 2005.tudy of patients who had undergone angiography demon-
trated lower use of revascularization and worse survival in
lacks (8), the only study to suggest a mortality difference
fter myocardial infarction (MI) found a lower adjusted
ortality rate for blacks as compared to their white coun-
erparts (9). Yet no prior study has examined racial differ-
nces in health status outcomes (symptoms, function, and
uality of life) after treatment for an acute coronary syn-
rome (ACS). This is a particularly glaring omission be-
ause patients are at least as concerned with the quality of
heir life as its quantity (10,11). More importantly, the
herapies shown to be applied differently to black and white
atients, most notably coronary revascularization, are pri-
arily used to improve patients’ health status and not their
urvival (12–14).
To provide new insights into potential racial disparities
n care, we prospectively studied the one-year outcomes
f a consecutive cohort of ACS patients. By documenting
nd adjusting for patients’ presenting sociodemographic,
linical, health status, and treatment characteristics, we
ought to determine whether one-year health status
utcomes differed between white and black patients.
ocumenting differences would underscore the need for
uture investigations to determine why such differences
xist and to define strategies for overcoming these dis-
arities in outcome.
MS
i
A
1
2
t
d
M
p
s
S
c
d
a
m
s
(
w
p
e
r
h
e
t
s
n
fi
a
s
f
a
h
o
b
o
i
i
C
g
c
I
T
o
o
N
p
p
c
p
p
p
s
a
w
a
fi
F
t
t
p
v
m
(
i
p
Q
w
(
c
r
v
d
a
a
i
a
b
l
s
n
s
r
t
S
n
o
n
t
w
p
t
A
a
n
S
f
a
1839JACC Vol. 46, No. 10, 2005 Spertus et al.
November 15, 2005:1838–44 Race and ACS Health Status OutcomesETHODS
tudy population. Patients were prospectively enrolled
nto an ACS registry at two Kansas City hospitals, the Mid
merica Heart Institute and Truman Medical Center. All
0,911 consecutive patients admitted between March 1,
001 and October 31, 2002 who had had a troponin blood
est ordered were screened for a possible ACS. Standard
efinitions were used to diagnose ACS patients with either
I (15) or unstable angina (16). Myocardial infarction
atients were defined by a positive troponin blood test in the
etting of symptoms or electrocardiogram changes (both
T-segment elevation and non–ST-segment elevation
hanges) consistent with an MI. Unstable angina was
iagnosed if the patient had a negative troponin blood test
nd any one of the following: new onset angina (2
onths) of at least Canadian Cardiovascular Society Clas-
ification class III, prolonged (20 min) rest angina, recent
2 months) worsening of angina, or angina that occurred
ithin 2 weeks of an MI (16). All potential unstable angina
atients who were found to have a diagnostic study that
xcluded obstructive coronary disease (i.e., coronary angiog-
aphy, nuclear or echocardiographic stress testing) or who
ad an additional diagnostic study confirming an alternative
xplanation for patients’ presentation (i.e., esophagogas-
roduodenoscopy) were subsequently excluded. Three phy-
icians reviewed the charts of all patients for whom diag-
ostic uncertainty remained and attained consensus on the
nal diagnosis.
Each participating patient was prospectively interviewed
s early as possible during their admission to ascertain their
ociodemographic, economic, and health status (symptoms,
unction, and quality of life) characteristics. Detailed chart
bstractions were performed to ascertain patients’ medical
istory, laboratory results, disease severity, and the processes
f inpatient care. Approval from the institutional review
oards of both institutions was obtained before the conduct
f the study, and an informed consent to participate in the
nterviews and chart abstractions was signed by each partic-
pant.
lassification of patients’ race. Congruent with the Con-
ressional Office of Management and Budget, race was
lassified by investigators as white, black, Asian, East
ndian, or other. Ethnicity was classified as Hispanic or not.
hese analyses focus upon the differences in health status
Abbreviations and Acronyms
ACS  acute coronary syndromes
CABG  coronary artery bypass grafting
MI  myocardial infarction
PCI  percutaneous coronary intervention
SAQ  Seattle Angina Questionnaire
SF-12 PCS  Short Form-12 Physical Component
Score
VA  Veterans Affairsutcomes between black and white patients. Patients of wther races and ethnicities (e.g., Pacific Islander, Asian, and
ative American; n  40) were excluded. To examine the
otential for misclassification of race, we conducted a
rospective study of 410 acute MI patients in which a data
ollector abstracted patients’ race from the chart and com-
ared this to patients’ self-reported racial designation. Using
atients’ designation as the gold standard, only three (0.7%)
atients were misclassified (one patient who classified them-
elves as black was considered white by chart abstraction,
nd two patients who considered themselves to be white
ere classified as black). Because the same data collectors
nd same hospitals were used for both studies, race classi-
cation in this study was considered accurate.
ollow-up data collection. The Social Security Adminis-
ration Death Master File was queried to determine pa-
ients’ vital status one year after enrollment. Surviving
atients were contacted by telephone for a follow-up inter-
iew that reassessed their clinical and health status. A
inimum of 12 attempts to contact patients were made
including contacting up to two additional individuals des-
gnated by patients at the time of their baseline interview as
eople who would know their whereabouts).
uantification of health status. Health status assessments
ere performed with the Seattle Angina Questionnaire
SAQ), a 19-item disease-specific measure for patients with
oronary artery disease that has well-established validity,
eproducibility, sensitivity to clinical change, and prognostic
alue (17–19). The SAQ quantifies five clinically relevant
imensions of coronary artery disease: physical limitation,
nginal stability, angina frequency, treatment satisfaction,
nd quality of life. A 5-point difference in mean SAQ scores
s considered clinically significant. The scales used in these
nalyses range from 0 to 100, where higher scores indicate
etter functioning, fewer symptoms, and higher quality of
ife. The Short Form-12 (SF-12) Version 1, a generic health
tatus measure that generates physical and mental compo-
ent scores, was also administered. A score of 50 on these
cales reflects the U.S. population mean, and each 10 points
eflects 1 SD from the mean.
The primary health status outcomes, chosen a priori for
hese analyses, were the SAQ Angina Frequency scale, the
AQ Quality of Life scale, and the SF-12 Physical Compo-
ent Summary (SF-12 PCS). The SF-12 was chosen instead
f the SAQ Physical Limitation scale because a substantial
umber of patients reported that they either did not perform
he activities described in the SAQ or that their limitations
ere due to reasons other than angina. Approximately 70% of
atients had no angina symptoms at one year; to accommodate
his distribution, and to improve scale interpretability, the
ngina Frequency scale was dichotomized into presence or
bsence of angina. The Quality of Life and Physical Compo-
ent scales were analyzed as continuous variables.
tatistical analysis. Black and white patients’ baseline and
ollow-up characteristics were compared. Categorical data
re reported as frequencies, and differences between groups
ere compared with chi-square tests. Continuous data are
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Race and ACS Health Status Outcomes November 15, 2005:1838–44eported as the mean SD, and differences between groups
ere tested using analysis of variance.
To describe the effect of race on patients’ one-year health
tatus outcomes, the following approach was used. First,
tatistical models of outcomes by race, controlling for
aseline health status, were conducted (general linear mod-
ls for the Quality of Life and Physical Component scales,
ogistic regression model for the presence of angina). Then,
o define the independent effect of race on outcome,
ultivariable models were constructed that sequentially
dded to the base model selected sociodemographic, clinical
both non-cardiac and cardiac disease severity), and treat-
ent characteristics that differed by race (p  0.10).
nalyses were performed with SAS version 8.2 (SAS
nstitute, Inc., Cary, North Carolina) and R version 1.8.0.
Several potential sources of missing data were present. First,
atients who died within 12 months of follow-up (n  81)
ould not have 1-year health status assessments made. These
atients were excluded from all analyses of health status, and
he presented results should be interpreted as representative of
hose who survive for at least one year after presenting with an
CS. In addition, 199 patients (17%) were not interviewed at
ne year, because they were unable to be contacted (n  144)
r refused to complete a one-year interview (n 55). Baseline
haracteristics of patients who were not interviewed were
ompared to those who were.
To examine whether a bias in our observed results might
ave occurred due to missing follow-up, propensity scores
ere computed using logistic regression analyses to predict
he likelihood of an unsuccessful interview. Predictor vari-
bles included patient demographic, socioeconomic, and
ifestyle factors; clinical characteristics; vitals and labs; dis-
ase severity; baseline health status; medications; and acute
nd non-acute treatments received during patients’ initial
CS hospitalization. Among the patients with available
ne-year data, analyses were replicated within tertile of
ropensity score—that is, within subgroups of increasing
isk of an unsuccessful interview—to examine the potential
or bias due to unobserved follow-up data. Tertiles were
hosen to provide sufficient subgroup sizes for examining
rends. In addition, a race-by-propensity score interaction
erm was added to the regression models to test the
onsistency of the race effect across risk for missing assess-
ents. No significant trend by risk of an unsuccessful
ollow-up interview was found in the race effects of the three
ne-year outcomes (p value for trend 0.4 for all), suggest-
ng that incomplete follow-up did not substantially influ-
nce our results.
For patients with follow-up who had partially complete
ata (e.g., missing baseline covariates or partially completed
uestionnaires), multiple imputation methods were used to
stimate the missing variables, and the analyses were repli-
ated on the imputed data (n  5 datasets). No significant
ifferences in effect sizes or statistical significance were
ound in the imputed datasets, so only the primary data are
resented. 1ESULTS
total of 196 black and 963 white patients participated in
his prospective registry. Black patients were younger (55 
1 vs. 63  13, p  0.001), more likely to be female (51%
s. 36%, p 0.001) and to have greater numbers of comorbid
edical conditions, including diabetes, hypertension, renal
ailure, current tobacco use, and obesity (Table 1). In contrast,
hite patients were more likely to have had prior revascu-
arization procedures and to have had higher Thrombolysis
n Myocardial Infarction (TIMI) risk scores among those
ith unstable angina or non–ST-segment elevation MI (3.0
1.4 vs. 2.4  1.3, p  0.001). White patients were less
ikely to have a history of heart failure (6% vs. 14%, p 
.001), but had a higher heart rate on admission (81  19
s. 77  17, p  0.001). With regards to invasive treat-
ents, whites were more likely to be treated with primary
ercutaneous coronary intervention (PCI) (32% vs. 10%, p
0.001), to undergo diagnostic angiography (86% vs. 55%,
 0.001), to have non-primary PCI (33% vs. 13%) and
ypass surgery (11% vs. 6%).
acial differences in one-year outcomes. One year after
dmission for an ACS, 7.1% of black patients and 7.0% of
hite patients had died (p  0.93). Figure 1 describes the
ealth status outcomes by race. One year after their ACS,
3.4% of black patients had angina as compared with only
7.1% of white patients (p  0.0001), and the mean SAQ
ngina Frequency score was significantly lower for black
atients (83.4  25.6 vs. 90.5  20.0, p  0.0001). The
istribution of patients with daily, weekly, monthly, and no
ngina was significantly worse among blacks (7.4% vs. 4.1%
ad daily angina, 11% vs. 7.3% had weekly angina, 25% vs.
5.6% had monthly angina, and only 56.6% of blacks
ompared to 73% of whites were without angina; p 
.0001). Similarly, the one-year SF-12 PCS scores were
ignificantly lower among black as compared with white
atients (36.8  12.3 vs. 43.2  11.4, p  0.0001). Finally,
he one-year SAQ quality of life scores were also signifi-
antly lower in black patients (70.6  28.3 vs. 83.9  20.8,
 0.0001) with 10.3% of blacks versus 3.2% of whites
eing quite-to-severely limited, 12.1% versus 6.7% being
oderately-to-quite limited, 29.3% versus 19% being
lightly-to-moderately limited, and 48.3% versus 71.1%
eing slightly-to-not-at-all limited. Replication of these
nalyses by type of ACS (i.e., ST-segment elevation MI,
on–ST-segment elevation MI, or unstable angina) did not
hange the magnitude or direction of the observed dispar-
ties in outcome.
ultivariable models of one-year outcomes. Even after
djustment for sociodemographic, clinical, and treatment
ifferences between white and black patients, the one-
ear health status outcomes were worse for black patients.
igure 2A diagrams the odds ratio of having angina one
ear after admission. After controlling for baseline angina
requency, blacks were 2.3-fold (95% confidence interval
.6 to 3.4) more likely to have residual angina. By sequen-
t
m
h
f
r
a
s
[
b
d
o
m
c
0
q
s
m
d
f
d
a
L
w
o
(
b
a
0
D
U
gment
yocar
1841JACC Vol. 46, No. 10, 2005 Spertus et al.
November 15, 2005:1838–44 Race and ACS Health Status Outcomesially controlling for sociodemographic factors (age, gender,
edical insurance), clinical factors (presenting syndrome,
ypertension, heart failure, diabetes, hyperlipidemia, renal
ailure, lung disease, smoking status, exercise patterns, prior
evascularization procedures, vitals, and TIMI risk scores),
nd hospital procedures (catheterization, primary reperfu-
ion, non-primary PCI vs. coronary artery bypass grafting
CABG] vs. medical therapy alone), the relative odds of
lacks having persistent angina at one year versus whites
ecreased. In the final model, blacks had a 46% greater odds
f having angina at one year (odds ratio 1.46) after adjust-
ent for all other factors, but the confidence interval
rossed 1.0 (95% confidence interval 0.91 to 2.34, p 
.11).
Figures 2B and 2C diagram the racial differences in
uality of life and physical function after controlling for the
Table 1. Baseline Patient Characteristics by Ra
Characteristics
Sociodemographics
Age
Male
No insurance
Insurance for medications
Clinical
Presenting syndrome
ST-segment elevation MI
Non–ST-segment elevation MI
Unstable angina
Hypertension
Prior MI
Prior percutaneous coronary intervention
Prior coronary artery bypass surgery
Prior heart failure
Diabetes
Hyperlipidemia
History of renal failure
Chronic lung disease
Cigarette smoking status
Current (30 days)
Former (30 days)
Never (or 100 cigarettes total)
Body mass index
Exercising 3 times/week before admission
Disease severity
Systolic blood pressure
Heart rate on admission
Most recent ejection fraction
TIMI risk score for UA/NSTEMI patients
TIMI risk score for STEMI patients
Hospital procedures
Coronary angiography
Primary angioplasty/stent
Non-acute treatment*
Medical
Percutaneous
Surgical
*Non-acute treatment refers to nonprimary revascularization
MI  myocardial infarction; NSTEMI  non–ST-se
elevation myocardial infarction; TIMI  Thrombolysis In Mame variables described above. After adjustment for all beasured differences between black and white patients,
isparities in health status outcomes persisted. Controlling
or baseline quality of life but without adjustment for
emographic, clinical, disease severity, and treatment char-
cteristics, the mean ( SEM) one-year SAQ Quality of
ife score was 13.2  2.2 points lower for blacks than
hites (p  0.001). After full adjustment, the quality of life
f blacks at one year was 7.7 2.4 points lower than whites
p  0.002). Similarly the SF-12 PCS scores of blacks in
aseline-adjusted and fully adjusted models were 4.6  1.2
nd 3.6  1.3 points lower than whites (p  0.001 and p 
.005, respectively).
ISCUSSION
sing a consecutive cohort of ACS patients, we found that
White
(n  963)
Black
(n  196) p Value
63  13 55  11 0.001
616 (64%) 96 (49%) 0.001
59 (30%) 93 (107%) 0.001
97 (50%) 702 (74%) 0.001
269 (28%) 32 (16%) 0.001
296 (31%) 54 (28%)
398 (41%) 110 (56%)
609 (63%) 152 (78%) 0.001
308 (32%) 66 (34%) 0.64
373 (39%) 22 (11%) 0.001
206 (21%) 18 (9%) 0.001
53 (6%) 28 (14%) 0.001
231 (24%) 78 (40%) 0.001
611 (63%) 91 (46%) 0.001
10 (1%) 13 (7%) 0.001
95 (10%) 32 (16%) 0.008
0.001
283 (30%) 93 (48%)
387 (40%) 57 (29%)
287 (30%) 45 (23%)
29  6 31  8 0.004
47 (24%) 306 (32%) 0.028
35  24 149  31 0.001
77  17 81  19 0.001
48  13 49  13 0.32
3.0  1.4 2.4  1.3 0.001
3.3  2.1 3.0  2.0 0.55
831 (86%) 107 (55%) 0.001
310 (32%) 20 (10%) 0.001
0.001
540 (56%) 158 (81%)
313 (33%) 26 (13%)
110 (11%) 12 (6%)
med after 24 h of admission.
elevation myocardial infarction; STEMI  ST-segment
dial Infarction; UA  unstable angina.ce
1
perforlack patients have worse health status one year after
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Race and ACS Health Status Outcomes November 15, 2005:1838–44reatment than whites. They were more than twice as likely
s whites to have angina at one year and had significantly
orse quality of life and physical function. Although ad-
ustment for clinical and treatment differences between
lack and white patients removed the statistical significance
f the 46% increased risk of angina, fully adjusted models
evealed that black patients had significantly worse quality
f life and greater physical limitations than whites one year
fter their ACS. These are the first data to find clinically
mportant differences in the health status of black and white
atients after ACS treatment and provide new insights into
acial disparities in care and outcomes.
Initial insights into racial differences in procedure use
ere demonstrated in 1988 when Wenneker and Epstein
igure 1. (A) Prevalence of angina at baseline and one year by race. (B)
uality of life at baseline and one year by race. (C) Physical function at
aseline and one year by race.20) reported that African Americans admitted to Massa- ahusetts hospitals for cardiovascular disease or chest pain
ere 72% (95% confidence interval 70% to 75%) as likely as
aucasians to receive coronary angiography. Since this
eport, numerous investigators have documented racial dif-
erences in the use of coronary angiography, PCI, and
ABG (3–5). For racial differences in procedure use to be
eaningful, however, it is important to determine that
bserved differences in treatment exist even after controlling
or other clinically important patient factors. Only if differ-
nces in care persist after controlling for these patient
haracteristics can they be attributed to the system that
elivers care rather than the clinical features of individual
atients. Unfortunately, health services research have con-
istently demonstrated, even after controlling for clinical
haracteristics, mechanisms of reimbursement, organization
f healthcare services, and availability of technology at
ndividual hospitals, that racial differences in care persist
3–5). While such data are extremely useful in understand-
ng that the process of care varies by race, these studies
annot address whether one group is receiving too many
rocedures or another group is receiving too few.
To understand whether true disparities (as opposed to
ifferences) in care are occurring, it is critically important to
ocument that adverse consequences (i.e., worse clinical
utcomes) occur as a result of differential treatment. A few
tudies have examined the outcomes associated with differ-
nt patterns of treatment. The first was a study by Peterson
nd colleagues (6) that examined both treatment and out-
omes within the Veterans Affairs (VA) healthcare system.
y examining all acute MI discharges from the VA in 1988,
989, and 1990, they showed that African Americans were
2% less likely to have angiograms, 42% less likely to
ndergo PCI, and 54% less likely to undergo CABG than
aucasians. Despite these differences, no difference in
ne-year or two-year mortality was observed. More recent
ork in the VA examined the processes of MI care, in
ddition to procedure use (7). This study revealed that
frican Americans were less likely to receive thrombolytic
herapy (32.4% vs. 48.2%, p  0.01) and CABG (6.9% vs.
2.5%, p  0.001), but, interestingly, no differences in the
se of angiography (49% vs. 50.3%, p  0.54) or PCI
15.4% for both groups) were found. Again, no differences
n adjusted mortality were observed at 90 days (odds ratio
.99 [95% confidence interval 0.74 to 1.3]), 1 year (odds
atio 0.86 [95% confidence interval 0.68 to 1.09]), or 3 years
odds ratio 0.93 [95% confidence interval 0.76 to 1.15]). In
act, the only study to suggest a mortality difference after MI
as reported by Chen et al. (9). While this study found that
frican American Medicare patients were less likely to
ndergo angiography after an MI, the adjusted mortality
ates of African Americans were lower than those of
aucasian patients (hazard ratio 0.87 [95% confidence
nterval 0.81 to 93] at one year and hazard ratio 0.89 [95%
onfidence interval 0.84 to 0.95] at three years). Thus,
espite obvious differences in the process of treating white
nd black patients, there are few data to support that
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November 15, 2005:1838–44 Race and ACS Health Status Outcomeseaningful differences in survival exist. It therefore appears
rom these previous studies that true disparities (i.e., mean-
ngful differences in outcome due to differences in care) are
ot present.
A critical limitation in these previous studies has been the
omplete omission of health status outcomes. After an acute
I, over 90% of patients survive, and the most relevant
onsiderations to these survivors are their symptoms, func-
ion, and quality of life. While substantial differences in the
se of angiography and revascularization may exist, the
rimary purpose of these procedures is to improve long-
erm symptom control and quality of life (excluding primary
evascularization with PCI, where a survival advantage may
xist [21]). This is the first study to report the health status
utcomes of a consecutive cohort of ACS patients to
etermine the influence of racial differences in treatment on
hese critically important outcomes.
In light of the substantial data documenting differences in
he use of angiography and revascularization between white
nd black patients, we anticipated that this would account
or most of the observed differences in health status out-
omes. Surprisingly, adjusting for in-hospital treatment did
ot eradicate the racial differences in health status outcomes.
hile adjustment for in-hospital revascularization removed
he statistically significant association of race and the pres-
nce of angina at one year, the effect sizes in the unadjusted
nd fully adjusted models were quite similar. In fact, larger
tudies may identify a persistent statistically significant
ifference. Furthermore, the important differences in quality
f life and physical function were not eliminated by adjust-
ent for the use of revascularization. These insights suggest
hat other factors in the care of patients between discharge
nd one year may be responsible for this disparity in
utcome. Recently scientists have clearly articulated the
hallenges in the conduct of clinical research of racial
ariations (22,23); thus, we are cautious in ascribing our
bserved differences to race alone. Because many factors
ontribute to one-year health status apart from patients’
linical characteristics and hospital care, and now that we
ave documented the presence of important disparities,
uture investigations will need to examine outpatient treat-
ents, compliance with antianginal medications, and bio-
ogic (e.g., genetic and metabolic) mechanisms that might
ffect these outcomes.
The principal limitation of this study is that it represents
he experience of only two Kansas City hospitals. However,
n light of these findings, important justification for exam-
ning the influence of race on health status outcomes from
more nationally representative population exists because
ifferences in care patterns at other settings may alter the
revalence of angina after an ACS and the impact of these
ymptoms on patients’ health status. A second concern is
hat 144 of our patients were lost to follow-up. Our
ropensity analyses suggest, however, that no significant
ias exists in our estimates of the racial differences inigure 2. (A) Multivariable-adjusted probabilities of angina at one year in blacks
ersuswhites. SeeTable 1 for variables in each category. (B)Multivariable-adjusted
ifference in one-year Seattle Angina Questionnaire Quality of Life score. See
able 1 for variables in each category. (C) Multivariable-adjusted difference in
ne-year Short Form-12 Physical Component score. See Table 1 for variables
n each category. B baseline health status; C clinical characteristics; D utcome. Finally, we only followed patients for one year.
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his work.
In conclusion, we have observed significant racial differ-
nces in health status outcomes after treatment for an ACS.
ore research is needed to better understand these differ-
nces and should specifically include an examination of the
utpatient processes of care as well as biologic determinants
metabolic and genetic) of outcome. In the meantime,
reater surveillance of the health status of black patients
ppears warranted so that those who are symptomatic,
hysically limited, or suffering a significant impairment in
heir quality of life can be identified and reevaluated for
urther treatment options.
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